Baxter Acetaminophen Injection Recall: Discoloration Hazard
Baxter Healthcare recalls acetaminophen injection with discoloration risk. Check product details to determine if affected. Stop using if discoloration observed.
Lower-risk recall
Discoloration
Contact the company
What happened, in plain English
Baxter Healthcare is recalling acetaminophen injection products that may have discoloration. This discoloration could indicate a potential issue with the product's safety, though the specific risk is not detailed in the recall notice. Read more at govinfonow.com/recall/31861-baxter-acetaminophen-injection-recall-discoloration-hazard.
Source Summary by GovInfoNow · govinfonow.com/recall/31861-baxter-acetaminophen-injection-recall-discoloration-hazard · Updated August 17, 2026 · FDA enforcement record: FDA #D-0596-2025
Cite this page
“Baxter Acetaminophen Injection Recall: Discoloration Hazard.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/31861-baxter-acetaminophen-injection-recall-discoloration-hazard. Based on FDA recall #D-0596-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0596-2025%22&limit=1).
Why it’s dangerous
Discoloration in the injection may indicate a problem with the product's stability or quality. However, the recall does not specify the exact risk or how discoloration could affect safety.
Who’s affected
Prescription holders of acetaminophen injection 1000 mg/100 mL (10 mg/mL) in 100 mL Viaflo containers. Patients using this medication for pain or fever relief are most at risk if discoloration is present.
How to tell if you have this one
Check for discoloration in the 100 mL Viaflo container. The product is labeled as acetaminophen injection 1000 mg/100 mL (10 mg/mL), prescription-only, made in Ireland with NDC 36000-306-60.
- Brand
Baxter Healthcare- Category
Drug
What to do — step by step
Check for Discoloration
Inspect the injection for any discoloration before use. If discoloration is present, do not use the product.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “U.S.A. Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 14 days after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
Questions people ask
What should I do if I have discoloration?
Do not use the product if discoloration is observed. Contact your healthcare provider for further instructions.
Similar recalls
Other Baxter Healthcare recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0596-2025 (August 20, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0596-2025 to see it in context.
- Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.